David R. Downey Jr., RPA

David Downey practices at Oswego Hospital in Oswego, New York, part of Oswego Health.

David Downey's NPI, 1225140536, was assigned on August 31, 2006. David Downey holds New York license 009502.

David Downey's primary practice is Oswego Hospital, at 110 West Sixth Street, Oswego, NY 13069 in Oswego County. The practice phone is (315) 349-5511.

David Downey's primary practice is Oswego Hospital in Oswego, New York, part of Oswego Health. The medical group on file is Oswego Health Medical Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where David Downey practices. Vendor and product names are available with a free account.

Medical is David Downey's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. David Downey is licensed in New York.

Dmand AI lists acute mini-stroke (TIA), chronic kidney disease, chronic obstructive pulmonary disease (COPD), fluid and electrolyte imbalances, sleep apnea and tobacco use among the conditions David Downey treats.

CMS data shows 1,076 Medicare services from David Downey across 6 procedure codes in 2024, for 412 Medicare patients. Medicare paid $48,970 for them. Every service was in an office.

CMS counts 412 Medicare patients who saw David Downey in 2024. The largest group is 75 to 84, with 151 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts David Downey's median patient age at 73, with 51% women.

In 2024, David Downey wrote 6,979 Medicare Part D claims for 1,340 patients. 77% of them were for generic drugs. CMS names the drug for 6,651 of them, across 59 drugs with 11 or more claims each, at $1,754,332 in total drug cost.

David Downey accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 43 general payments to David Downey from 16 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $211.